* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Gene Disorders1(Saffen)
No-SCAR (Scarless Cas9 Assisted Recombineering) Genome Editing wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Nutriepigenomics wikipedia , lookup
Genetic code wikipedia , lookup
Fetal origins hypothesis wikipedia , lookup
Genetic engineering wikipedia , lookup
Saethre–Chotzen syndrome wikipedia , lookup
History of genetic engineering wikipedia , lookup
Cell-free fetal DNA wikipedia , lookup
Koinophilia wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
Genetic drift wikipedia , lookup
Tay–Sachs disease wikipedia , lookup
Public health genomics wikipedia , lookup
Epigenetics of neurodegenerative diseases wikipedia , lookup
Designer baby wikipedia , lookup
Quantitative trait locus wikipedia , lookup
Genome (book) wikipedia , lookup
Oncogenomics wikipedia , lookup
Medical genetics wikipedia , lookup
Neuronal ceroid lipofuscinosis wikipedia , lookup
Population genetics wikipedia , lookup
Dominance (genetics) wikipedia , lookup
Frameshift mutation wikipedia , lookup
Medical Genetics: Single Gene Disorders Lecturer: David Saffen. Ph.D. Laboratory for Molecular Neuropsychiatric Genetics Department of Cellular and Genetic Medicine School of Medicine, Fudan University [email protected] Outline A. Historical Background B. Patterns of inheritance C. Genetic mutations D. Prenatal diagnosis A. Historical Background • Gregor Mendel • Archibald Garrod • Thomas Hunt Morgan • Linus Pauling Gregor Mendel Established the rules of inheritance of discrete traits in plants, providing the foundation for the discovery of the gene and the establishment of the modern science of genetics Mendel’s Laws: Law of Segregation: Each individual possesses two factors (alleles) for a given trait, which “segregate” during the formation of gametes in such a manner that each gamete contains only one of the factors (alleles). Progeny subsequently receive one factor (allele) from their father and one factor (allele) from their mother Law of Independent Assortment: Factors (alleles) for distinct traits are inherited independently, i.e. the inheritance of a factor (allele) for one trait does not Influence the inheritance of a factor (allele) for a second trait. 1822-1884; German-speaking Augustinian friar in Brno, Silesia (currently Czech Republic) Archibald Garrod Postulated that recessive metabolic disorders resulted from the inheritance of a defective enzyme from each parent. Garrod’s tetrad: alkaptonuria, cystinuria, pentosuria, albinism 1857- 1936; British physician Professor Oxford University; Published Inborn Errors of Metabolism” in 1908 Urine samples from patient with alkaptonuria. Left (freshly voided); right (after 24 h at RT) Cystinuria (caused by defects in the SLC3A1 and SLC7A9 transporter genes) Xylulose accumulates in the urine of patients with pentosuria. (caused by L-xylulase deficiency) Albinism (caused by a deficiency of tyrosinase, a enzyme required for the synthesis of melanin) Thomas Hunt Morgan Working with Drosophila, established that gene are carried on chromosome and form the functional basis of heredity: essentially establishing the modern science of genetics Tan Jiazhen (谈家桢) “Father of modern genetics in China” Link with Fudan University: 1909-2008 1866- 1945; American Geneticist Professor Columbia and California Institute of Technology; Nobel Prize: Physiology or Medicine 1933 Linus Pauling First to demonstrate of the molecular basis of a genetic disease, sickle cell anemia: essentially establishing the field of molecular genetics Sickle-like appearance of red blood cell isolated from sickle cell anemia patient (left) compared to normal red blood cell (right). Electrophoresis of CO-hemoglobin isolated from normal Individual (a) or individuals heterozygous (b) or homozygous (c) for hemoglobin mutation. 1901-1994; American quantum chemist and biochemist. Professor at the California Institute of Technology & Stanford University Nobel Prizes: Chemistry 1954; Peace 1962; Published: Itano I et al, “Sickle Cell Anemia, a Molecular Disease” Science 110, 1488-1490, 1949 B. Patterns of inheritance within pedigrees Autosomal dominant Penetrance and expressivity Autosomal recessive Consanguinity and inbreeding Co-dominant Incompletely dominant X-linked dominant X-linked recessive Y-linked Probands and pedigrees “Punnett squares” Genotype = combination of alleles at a specific locus A Sperm A-allele Sperm a-allele Eggs A-allele AA aA Eggs a-allele Aa aa Sperm A-allele Sperm a-allele Eggs A-allele AA aA Eggs a-allele Aa aa a A = normal (major) allele a = mutated (minor) allele unaffected affected Autosomal dominant inheritance A = normal (major) allele a = mutated (minor) allele Sperm A Sperm a Eggs A AA Aa Eggs A AA Aa 1/2 of offspring affected Sperm a Sperm a Eggs A aA aA Eggs A aA aA all offspring affected Sperm a Eggs A AA aA Eggs a Aa aa 3/4 of offspring affected Sperm a Sperm a Eggs A aA aA Eggs a aa aa all offspring affected Sperm A Sperm a Sperm a Eggs a aa aa Eggs a aa aa all offspring affected Example: Neurofibromatosis type 1 (NF1) An autosomal dominant disorder caused by inactivation of one copy of the neurofibromin gene (NF1) located at 17q11.2. Incidence of NF1 = ~1/3500 births; 80% of mutations are paternal in origin. Aa de novo mutation inherited from father Aa AA AA AA 1/2 of offspring affected Sperm A Sperm a Eggs A AA Aa Eggs A AA Aa Aa 1/2 of offspring affected A = normal (major) allele a = mutated (minor) allele Penetrance and expressivity Penetrance: the probability that a genetic variant will have a detectable phenotype (this is an all-or-nothing classification): Variable penetrance: describes variants with less than 100% penetrance Expressivity: the severity of expression of the phenotype Variable expressivity: describes phenotypes that vary among individuals with the same genotype Expressivity of neurofibromatosis type 1 phenotype Café-au-lait spots (black arrows) And cutaneous neurofibroma (white arrow) Disseminated cutaneous and subcuntaneous neurofibromas Lisch nodules (iris hamartomas) Distended eye due to pressure from tumor on optic nerve Autosomal recessive inheritance Aa Aa aa aa A = normal (major) allele a = mutated (minor) allele Sperm A Sperm a Eggs A AA aA Eggs a Aa aa 1/4 of offspring affected Sperm A Sperm a Eggs a Aa aa Eggs a Aa aa 1/2 of offspring affected Sperm a Sperm a Eggs a aa aa Eggs a aa aa all offspring affected Example: Cystic fibrosis (CF) An autosomal recessive disorder caused by mutations in the CF transmembrane regulator gene (CFTR) located at 7q31.2. Large differences in frequency of CFTR mutations in different populations: ~1/25 among Northern Europeans; ~1/500 in Asian populations Symptoms include: abnormal chloride ion transport in exocrine tissues leading to the accumulation of mucus in lungs, sinuses, intestines, pancreas and male reproductive tract. Accompanying bacterial infections and inflammation cause tissue damage and organ failure. Expression of CF symptoms is highly variable. CBAVD = congenital absence of vas deferens Lung from cystic Fibrosis patient Consanguinity and inbreeding 1.0 Aa Aa Aa 0.0 0.5 0.5 Probabilities that an individual harbors one or two copies of the A1 allele Aa 0.25 0.25 aa 0.0625 = 1/16 F = probability that a homozygote has received both alleles at a locus from the same ancestor; i.e. that the alleles are identical-by-decent (IBD)* *Note: alleles that produce the same phenotype, but at not known to be IBD are termed identical-by-state (IBS). Example: Xeroderma pigmentosum (XP) A rare, autosomal recessive disorder caused by mutations in genes encoding enzymes required for repair of ultra violet light-damaged DNA. Eight subtypes have been defined, based upon mutations in different genes. The classical form is caused by mutations in the XP complementation group A gene (XPA) located at 9q22.3, which encodes a “zing finger” protein required for nucleotide excision repair. The inability to repair damaged DNA gives rise to malignant melanoma and basal cell and squamous cell carcinomas. Prevalence in US and Europe: ~1/1,000,000; prevalence in Japan ~1/100,000; 20% of cases derive from offspring of marriages between first cousins. Co-dominant inheritance Example: the ABO blood types are determined by three variants of the alpha 1-3-galactosyltransferase gene (ABO), located at 9q34.2. The “A” variant produces the “A” antigen on the surface of red blood cells by adding an N-acetylgalactosamine residue to a cell surface glycoprotein called H-antigen. Similarly, the “B” variant produces “B” antigen by adding a D-galactosamine residue to H-antigen. By contrast, the “O” variant is inactive, resulting in red blood cells with unmodified H-antigen on the cell surface. Variants A and B are dominant with respect to the O variant, but co-dominant with respect to each other. A B O A A AA AB AO B B AB BB BO AB O AO BO OO O Incompletely dominant inheritance [homozygotes more severely affected than heterozygotes] Example: Acondroplasia, the most common form of dwarfism, is caused by specific mutations in the fibroblast growth factor receptor subtype 3 gene (FGFR3), located at 4p16.3. Two mutations: 1138G>A (~98%) and 1138G>C (~1-2%) account for 99% of cases. These are gain-of-function mutations that change the amino acid sequence of FGFR3 In such a way that causes the receptor to become constitutively active. The incidence of acondroplasia is 1/15,000 to 1/40,000 in all ethnic groups. De novo mutation Of 1138G occur exclusively in the paternal germ Line and the frequency increases with age (>35 years). Homozygous achondroplasia is lethal. Note: when modeling the contributions of genetic variants to a disease, the variants are often assumed to have additive effects: homozygotes carrying a liability variant are assumed to be roughly two-fold more severely affected than heterozygotes or two-fold more likely to be diagnosed with the disease. X-linked dominant inheritance with male lethality Disorder is observed in ~50% of daughters of affected mothers; Males die during prenatal period. Expressivity in affected females Varies with underlying pattern of X-inactivation Example: Rett syndrome Xq28: methyl CpG binding protein 2 gene (MECP2) gene Prevalence among females: 1/10,000 – 1/15,000. rarely observed in 47, XXY males. Mutations in MEPC2 are thought to interfere with transcriptional silencing and epigenetic regulation of genes in regions of methylated DNA, leading to inappropriate activation of gene expression. Symptoms include small brains with cortical and cerebellar Atrophy without loss of neurons (smaller cells with fewer dendritic branches); motor disabilities; stereotypic hand-wringing and circulating hand-mouth movements, epilepsy, autism DNMT1 = DNA (cytosine-5) methyltransferase 1 HDAC = histone deacetylase X-linked recessive inheritance Female carrier: May be unaffected or suffer variable symptoms depending upon pattern of X inactivation Example: Hemophilia A and B [Xp28 (F8=cofactor) and Xp27.1-p27.2 (F9= protease)] Incidence: ~1/5000 (F8) and ~1/100,000 (F9) newborn males Severity of symptoms depends on residual Factor VIII or IX activity: severe (<1%); moderate (1%-5%); mild (5%-25%); Clotting factor replacement has extended life expectancy from 1.4 year in early 1900’s to 65 years today. Y-linked inheritance Example: azoospermia caused by deletions in AZF regions of the Y-chromosome Normal testis Sertoli cell only testis Locus heterogeneity Example: Charcot-Marie-Tooth Neuropathy 39 CMT risk loci Disease modifier genes Example: cystic fibrosis Gene Pulmonary Function (FEV1) Pseudomonas aeruginosa acquisition/ colonization ADIPOR2 ++ IFRD1 + ILS + MBL2 ++ Liver Disease ++ MSRA + - - TCF1I2 TBFB1 Diabetes + EDNRA SERPINA1 Intestinal Obstruction + + ++ - + Ref: Cutting GR, Modifier genes in Mendelian disorders: the example of cystic fibrosis, Ann NY Acad Sci 1214, 57-69, 2010 Founder mutations and the risk of genetic disorders in isolated populations Example: Tay-Sachs disease (recessive inheritance) Multigenerational pedigree demonstrating common remote common ancestors in Cajun population * * * * * * * ** * * * * * * * * * * ** * ** * ** *Heterozygous for hex A a-subunit exon 11 insertion; **Homozygous for hex A a-subunit exon 11 insertion *Heterozygous for G to A transition in spice donor site in intron 9 of hex A a-subunit Maintenance of deleterious mutations in the population: Heterozygote advantage Prevalence of Malaria (left) and sickle-cell disease (right) in Africa Recessive genetic disorders with suspected heterozygote advantage Disorder Heterozygotes resistant to: Sickle-cell anemia Malaria Thalassemia Malaria Primaquine/fava bean-induced hemolysis (glucose-6-phosphate dehydrogenase deficiency) Malaria Cystic fibrosis Cholera Tuberculosis Chronic obstructive lung disease (emphysema) cirrhosis of liver (a1-antitrypsin deficiency) Tuberculosis C. Genetic mutations • Point mutations Coding sequence mutations Mutations affecting RNA splicing Promoter mutations • Indels • Repeat expansions Intergenerational “anticipation” Missense mutations Example: sickle-cell disease Note: this is an example of a gain-of-function mutation Nonsense mutations and nonsense-mediated mRNA decay (NMD) Examples: Tryptophan-to-stop codon mutation in PAX3 and nonsense mutations in PAX10 PAX3 PAX10 NMD: complete loss-of-function (Waardenburg syndrome: hearing loss, pigmentation abnormalities, Hirschsprung disease) Mutant “gain-of-function” proteins (Severe neurological deficits) Nonsense mutations and nonsense-mediated mRNA decay (NMD) Examples: Tryptophan-to-stop codon mutation in PAX3 and nonsense mutations in PAX10 PAX3 PAX10 NMD: complete loss-of-function (Waardenburg syndrome: hearing loss, pigmentation abnormalities, Hirschsprung disease) Mutant “gain-of-function” proteins (Severe neurological deficits) Mutations affecting RNA splicing Exon Intron * CFTR (CF transmembrane conductance regulator) Novel, deleterious splice site: frame-shifted aa sequence containing termination codons ** ** *MITF = microphthalmiaassociated transcription factor (mutations cause Waardenburg syndrome type 2) **SMN1 survival of motor neuron 1 SMN2 survival of motor neuron 2 (mutations in SMN1 cause spinal muscular atrophy) Promoter mutations Example: clotting factor IX (Leyden) Small insertions and deletions (indels) Example: Frame-shift mutation in Tay-Sachs disease In the absence of hex A activity GM2 ganglioside accumulates in the brain, causing neurological damage and death by age 2 to 4. Insertion of four nucleotides into exon 11 of hexosaminidase A gene shifts the reading frame and introduces a premature stop codon The rate of de novo mutations increase with father’s age Ref: Kong A et al, Rate of de novo mutation and the importance of father’s age to disease risk, Nature 488, 471-475, 2012 Repeat expansions Huntington disease Progressive and fatal neurodegenerative disorder that produces uncontrolled movements cognitive deficits and emotional disturbances. All areas of the brain affected, with particularly extensive damage to striatum (caudate nucleus and putamen) Dominant inheritance, with symptoms typically appearing In middle age. Currently ~ 15,000 HD patients In US, with an additional 75,000 Pre-onset heterozygotes. Age 50 Proposed mechanism of repeat expansion Inter-generational “anticipation”: progressive increase in repeat length and decrease in age of onset in an HD pedigree Ref: Ranen et al, American Journal Human Genetics 57, 593-6022, 1995 Catalog of Mendelian disorders Mendelian Inheritance in Man http://www.ncbi.nlm.nih.gov/omin/ To date, causative genetic variants for approximately 3,000 Mendelian disorders have been identified D. Prenatal diagnosis of genetic disorders: Amniocentesis and chorionic villus sampling (CVS) Note: fetal blood can be directly obtained from the umbilical cord (cordocentesis). Non-invasive methods for prenatal diagnosis Note: AFP = alpha-fetoprotein Non-invasive genetic tests PLoS One. 2012;7(5):e38154. doi: 10.1371/journal.pone.0038154. Epub 2012 May 29. Noninvasive prenatal diagnosis of fetal trisomy 21 by allelic ratio analysis using targeted massively parallel sequencing of maternal plasma DNA. Liao GJ, Chan KC, Jiang P, Sun H, Leung TY, Chiu RW, Lo YM. Centre for Research into Circulating Fetal Nucleic Acids, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, China. Science Translational Medicine. 2012 Jun 6;4(137):137ra76. Noninvasive whole-genome sequencing of a human fetus. Kitzman JO, Snyder MW, Ventura M, Lewis AP, Qiu R, Simmons LE, Gammill HS, Rubens CE, Santillan DA, Murray JC, Tabor HK, Bamshad MJ, Eichler EE, Shendure J. Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA. References and further reading RI Nussbaum, RR McInnes and HF Willard, “Thompson & Thompson Genetics in Medicine, Edition 7,” 2007, Saunders Elsevier, Philadelphia, PA; ISBN: 978-1-4160-3080-5 (Chapters 7 and 15) T Strachan and A Read, “Human Molecular Genetics, 4th Edition,” 2011, Garland Science, New York, New York ISBN: 978-0-815-34149-9 (Chapter 13)